Search

everythinglearnresearchcommunity

for

Search:↓

Fibrosis in the bulge area of hair follicles can cause hair thinning in male pattern baldness, and drugs that inhibit fibrosis might help reverse this.

Formononetin may help protect the brain and treat neurological diseases.

The conclusion is that fat tissue in the skin is a new finding in Frontal fibrosing alopecia and may contribute to hair follicle and muscle degeneration.

Alzheimer's may be treated by targeting gut bacteria and inflammation.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Focal atrichia helps diagnose female pattern hair loss.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

GABA contributes to stress-related hair loss, and ginkgolide A may help treat it.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Progerin affects cell shape but not hair or skin in mice.

Allopregnanolone changes gene expression in glioblastoma cells.

GPC1 is important for blood vessel growth in hair follicles and could help treat hair loss.

Cerebronal® may help improve certain brain health markers.

BTNL2 helps protect hair follicles from immune attacks.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

Fetal skin biopsy can help diagnose protein-related disorders before birth.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

TGF-β1 and 2 may play a role in hair loss in AGA.

Hutchinson-Gilford Progeria Syndrome caused rapid aging due to a genetic mutation, with treatments to manage symptoms.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.

ASLNC168501 can help treat hair loss by restoring hair follicle stem cell function.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Certain genetic variants in ERN1, TACR3, and SPPL2C are linked to when Alzheimer's disease starts.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

KeraGLO improves skin and hair health.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.